Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
Alekseeva AA, Moiseeva EV, Onishchenko NR, et al. Int J Nanomedicine. 2017;12:3735–3749. On page 3735, the first author’s name was incorrectly listed as Anna A Alekseeva. Her correct name is Anna S Alekseeva.Read the original article
Guardado en:
Autores principales: | Alekseeva AS, Moiseeva EV, Onishchenko NR, Boldyrev IA, Singin AS, Budko AP, Shprakh ZS, Molotkovsky JG, Vodovozova EL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/192b5a72de474305ab6c722fe48734dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma
por: Alekseeva AA, et al.
Publicado: (2017) -
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
por: Xing J, et al.
Publicado: (2019) -
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Nagsen Gautam, et al.
Publicado: (2021) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
por: Lars Velten, et al.
Publicado: (2021) -
Suppression of Transposable Elements in Leukemic Stem Cells
por: Anthony R. Colombo, et al.
Publicado: (2017)